Disclosures for "Novel Approach to Optimization of Alzheimer’s Vaccine Configuration for Maximal Targeting of Toxic Amyloid-Beta Oligomers"
-
Dr. Kaplan has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Kaplan has stock in ProMIS Neurosciences. Dr. Kaplan has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Gibbs has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Promis Neurosciences.
-
The institution of Dr. Napper has received research support from NSERC. The institution of Dr. Napper has received research support from Westin Foundation.
-
Ms. Scruten has nothing to disclose.
-
Ms. Coutts has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ProMIS Neurosciences, Inc..
-
Dr. Cashman has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Cashman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IONIS. Dr. Cashman has stock in ProMIS Neurosciences. The institution of Dr. Cashman has received research support from ProMIS Neurosciences. Dr. Cashman has received intellectual property interests from a discovery or technology relating to health care.